Creative Biolabs

Exosome Products

As natural carriers with exceptional safety, low immunogenicity, and inherent targetability, exosomes have emerged as a powerful solution for addressing the complex challenges of modern drug delivery. Their ability to precisely deliver therapeutic payloads while navigating biological barriers makes them a cutting-edge tool in areas like genomics research. At Creative Biolabs, we provide a comprehensive suite of exosomes products and expert services, enabling researchers to harness these advantages for their groundbreaking work in exosome-based drug carriers and beyond.

Overview

Exosomes have emerged as a powerful tool in modern targeted drug delivery, providing a versatile platform for the encapsulation and protection of a wide array of therapeutic payloads. These naturally occurring extracellular vesicles (30−150 nm in size) are secreted by virtually all cells and act as biological messengers. Their fundamental role is to shield sensitive molecules, such as proteins, lipids, and nucleic acids, from degradation while facilitating their transport across biological barriers to the intended site of action. This natural mechanism of intercellular communication, combined with recent advancements in isolation and engineering, has positioned exosomes as highly selective drug carriers, particularly for exosome RNA delivery and exosomes for gene therapy.

Innate Targeting

Possess specific surface proteins that can be harnessed for targeted delivery to desired cells and tissues.

High Biocompatibility

Naturally-derived from cells, leading to low immunogenicity and a reduced risk of adverse immune reactions.

The advantages of exosomes. (Creative Biolabs Original)

Long Circulation Half-Life

Their innate stealth properties help them evade immune surveillance, extending their presence in the bloodstream for more effective delivery.

Ability to Cross Biological Barriers

Their small size and unique surface chemistry allow them to naturally traverse complex physiological barriers, including the blood-brain barrier (BBB).

Explore Our Product Portfolio

View All Products

Discover the perfect exosomes products for your research.

Exosome Standard

A diverse range of high-purity (>95%) exosomes derived from various cells, milk, and plants, ideal for establishing robust experimental controls.

Exosome Labeling Dyes

Our dyes enable precise tracking and visualization of exosomes in cell- and animal-based studies, essential for analyzing their biodistribution and cellular uptake.

Exosome Preservation Solution

Ensures the long-term stability and integrity of isolated exosomes, preserving their biological function for future research applications.

Lysis Buffer for Exosomes

A proprietary buffer for the efficient and gentle lysis of exosomes, allowing for the extraction of nucleic acids and proteins for downstream analysis.

While exosomes are a key focus, we also provide a range of complementary modular delivery systems to enhance your research, and our experts are ready to help you integrate them to create a customized solution. These include: liposome, LNP, and targeted modules (peptides, aptamers, etc.).

Need a Custom Solution?

Request a Custom Service Consultation

Groundbreaking research in targeted drug delivery often requires a unique approach that off-the-shelf products cannot satisfy. At Creative Biolabs, we specialize in collaborating with you to address these complex challenges, providing a comprehensive range of tailored exosome therapeutics services. Our deep expertise in exosome manufacturing and exosome characterization allows us to transform your innovative ideas into tangible, high-performance delivery solutions, ensuring your research is never limited by the tools available.

Exosome Characterization & Analysis

Comprehensive services using cutting-edge techniques like Transmission electron microscopy analysis and NTA particle size analysis to validate the purity and characteristics of your exosome preparations.

Exosome Encapsulation & Loading Services

Optimizing protocols for the efficient and stable loading of your unique payloads, from small molecules to large nucleic acids, into exosomes.

Engineered Exosomes

Developing custom exosomes with modified surface proteins or other features to enhance targeting efficiency and therapeutic function.

Exosome Isolation & Identification

Providing optimized workflows to isolate and identify high-purity exosomes from various sources.

Genomics Research

Utilizing our expertise in nucleic acid analysis to help you profile the genetic cargo of exosomes for biomarker discovery or gene therapy applications.

Applications of Exosomes

Applications of our advanced exosomes. (Creative Biolabs Authorized)
  • Genomics Research: Analyzing the nucleic acid cargo of exosomes for non-invasive liquid biopsy, biomarker discovery, and monitoring disease progression.
  • Exosomes for Gene Therapy: Using exosomes as natural vectors for delivering siRNA, mRNA, and RNA-guided gene editing systems to precisely modulate gene expression.
  • Cytological & Zoological Experiments: Tracking exosome biodistribution and cellular uptake in both in vitro and in vivo models to study their role in intercellular communication and disease.
  • Exosome Therapeutics: Developing exosomes loaded with drugs or proteins for targeted delivery in oncology, neurodegenerative diseases, and regenerative medicine.
  • Nucleic acid-protein analysis: Characterizing the molecular cargo of exosomes to understand their biological function and identify new therapeutic targets.
  • Immunology: Leveraging the immunomodulatory properties of exosomes for novel vaccine strategies and the treatment of inflammatory diseases.
  • Neurodegenerative Diseases: Utilizing exosomes' natural ability to cross the BBB for the delivery of therapeutic agents to the central nervous system.

Why Choose Creative Biolabs?

Product Ordering Process

Process of placing an order. (Creative Biolabs Original)

FAQs

What is the benefit of using different sources for exosomes?

Exosomes from different sources, such as milk, plants, or various cell lines, carry distinct molecular signatures and exhibit unique tropism and therapeutic properties. Using a diverse range of standard samples helps researchers select the most suitable source for their specific application, from bioavailability to tissue-specific targeting.

What is the primary advantage of using exosomes over synthetic drug carriers like LNPs?

Exosomes have several key advantages, including their natural origin, which leads to lower immunogenicity. They also possess an innate ability to home to specific tissues and can cross biological barriers more effectively, making them particularly promising for challenging delivery sites like the central nervous system.

Can your exosome products be used in my cytological and zoological experiments?

Yes, our Exosome fluorescent labeling dyes and standard samples are designed specifically for these types of applications. They allow you to visualize and track exosome uptake and trafficking in both in vitro cell cultures and in vivo animal models.

What information do I need to provide for a custom development inquiry?

To start, we need to understand your payload, target cell/tissue, and the key challenges you are facing. Any data you have on stability, solubility, or initial in vitro results is also helpful. Our team will guide you through the process and help define the project scope.

Filter:

[CAT#: TDLD-0126-LD1296]
PC-3 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: PC-3 Cell (Human Prostate Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1315]
Saliva-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Saliva (Human Saliva)
Concentration: >1*10^9 Particles/mL
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Jurkat Clone E6-1 Cell (Human T lymphocyte Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1285]
K562 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: K562 Cell (Human Chronic Myeloid Leukemia Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1287]
LnCAP Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: LnCAP Cell (Human Prostate Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1273]
H196 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: H196 Cell
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1272]
DMS114 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: DMS114 Cell (Human Small Cell Lung Cancer Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1266]
BPH-1 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: BPH-1 Cell (Human Benign Prostatic Hyperplasia Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1317]
Exosome Inhibitor
Category: Exosome Inhibitor
Category: Exosome Culture Media
[CAT#: TDLD-0126-LD1279]
HT1080 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: HT1080 Cell (Human Fibrosarcoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1301]
SK-BR-3 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: SK-BR-3 Cell (Human Breast Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Kluyveromyces Lactis (a species of yeast)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1263]
B16F10 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: B16F10 Cell (Murine Melanoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1274]
H841 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: H841 Cell (Human Cell Line)
Concentration: >1*10^9 Particles/mL
Category: Exosome Culture Media
[CAT#: TDLD-0126-LD1291]
MM1 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: MM1 Cell
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1271]
DAUD1 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: DAUD1 Cell
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1294]
Human NK Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Human NK Cell (Human Natural Killer Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1307]
Urine-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Urine (Human Urine)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1316]
Exosome Storage Buffer
Category: Exosome Storage Buffer
Category: Exosome Culture Media
[CAT#: TDLD-0126-LD1295]
Ntera-2 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Ntera-2 Cell (Human Embryonic Carcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1308]
Milk-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Milk (Bovine Milk)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1259]
293T Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: 293T Cell (Human Embryonic Kidney Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1264]
BC-3 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: BC-3 Cell (Human B-Cell Lymphoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1269]
COLO1 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: COLO1 Cell (Human Colorectal Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1319]
Exosome Fluorescent Dye (PKH26)
Category: Exosome Dyes
Category: Exosome Culture Media
[CAT#: TDLD-0126-LD1281]
Huh7 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Huh7 Cell (Human HepatoCellular Carcinoma Cells)
Concentration: >1*10^9 Particles/mL
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Dendrobium Officinale (Aerial Parts of Dendrobium officinale Kimura et Migo)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1265]
BLCL21 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: BLCL21 Cell (Human B Lymphoblastoid Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1260]
A373 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: A373 Cell (Human Embryonic Kidney Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1292]
Mouse Serum-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Mouse Serum
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1329]
MSC-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: MSC (Mesenchymal Stem Cells)
Concentration: >1*10^9 Particles/mL
Category: Exosome-Depleted Media
[CAT#: TDLD-0126-LD1299]
RAW 264.7 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: RAW 264.7 Cell (Murine Macrophage Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1270]
COLO205 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: COLO205 Cell (Human Colorectal Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1282]
JAWS II Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: JAWS II Cell (Murine Bone Marrow-Derived Dendritic Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1302]
SK-N-SH Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: SK-N-SH Cell (Human Neuroblastoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1275]
HCT116 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: HCT116 Cell (Human Colorectal Carcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1283]
JM1 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: JM1 Cell (Human Bone Marrow Mesenchymal Stem Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1320]
Exosome Fluorescent Dye (PKH67)
Category: Exosome Dyes
[CAT#: TDLD-0126-LD1309]
Grape-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Grape
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1288]
MCF-7 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: MCF-7 Cell (Human Breast Adenocarcinoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1261]
A375 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: A375 Cell (Human Melanoma Cells)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1310]
Exosome-Depleted FBS
Category: Exosome-Depleted Media
[CAT#: TDLD-0126-LD1258]
293F Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: 293F Cell (Human Embryonic Kidney Cells)
Concentration: >1*10^9 Particles/mL
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: Pichia Pastoris (Methylotrophic Yeast)
Concentration: >1*10^9 Particles/mL
[CAT#: TDLD-0126-LD1290]
MG63 Cell-Derived Exosomes
Category: Exosome Standards
Format: Liquid; Lyophilized
Source: MG63 Cell (Human Osteosarcoma Cells)
Concentration: >1*10^9 Particles/mL
Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations